Bicara Therapeutics Common Stock Price on December 1, 2024
| BCAX Stock | 20.79 0.17 0.81% |
If you're considering investing in Bicara Stock, it is important to understand the factors that can impact its price. As of today, the current price of Bicara Therapeutics stands at 20.79, as last reported on the 1st of December, with the highest price reaching 22.20 and the lowest price hitting 20.40 during the day. Bicara Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Bicara Therapeutics secures Sharpe Ratio (or Efficiency) of 0.07, which signifies that the company had a 0.07% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Bicara Therapeutics Common, which you can use to evaluate the volatility of the firm. Please makes use of Bicara Therapeutics' risk adjusted performance of 0.0627, and Mean Deviation of 3.59 to double-check if our risk estimates are consistent with your expectations.
Total Stockholder Equity is likely to drop to about (156.2 M) in 2024. Capital Stock is likely to drop to 1,600 in 2024. Bicara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Bicara |
Sharpe Ratio = 0.07
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BCAX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.82 actual daily | 51 51% of assets are less volatile |
Expected Return
| 0.41 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Bicara Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bicara Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.154 | Book Value (5.10) | Enterprise Value 577.3 M | Shares Float 29.6 M | Shares Outstanding 54.4 M |
Bicara Therapeutics Valuation on December 1, 2024
It is possible to determine the worth of Bicara Therapeutics on a given historical date. On December 1, 2024 Bicara was worth 21.0 at the beginning of the trading date compared to the closed value of 20.79. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bicara Therapeutics stock. Still, in general, we apply an absolute valuation method to find Bicara Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bicara Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bicara Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 21.00 | 22.20 | 20.40 | 20.79 | 189,395 | |
12/01/2024 | 21.00 | 22.20 | 20.40 | 20.79 | 0.00 |
| Backtest Bicara Therapeutics | | | Bicara Therapeutics History | | | Bicara Therapeutics Valuation | Previous |
Bicara Therapeutics Trading Date Momentum on December 1, 2024
| On December 01 2024 Bicara Therapeutics Common was traded for 20.79 at the closing time. The top price for the day was 22.20 and the lowest listed price was 20.40 . There was no trading activity during the period 0.0. Lack of trading volume on December 1, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.01% . |
Bicara Therapeutics Fundamentals Correlations and Trends
By evaluating Bicara Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bicara Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bicara financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bicara Therapeutics Stock history
Bicara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bicara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bicara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bicara Therapeutics stock prices may prove useful in developing a viable investing in Bicara Therapeutics
Bicara Therapeutics Stock Technical Analysis
Bicara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bicara Therapeutics Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Bicara Therapeutics Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bicara Therapeutics December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Bicara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bicara Therapeutics shares will generate the highest return on investment. By undertsting and applying Bicara Therapeutics stock market strength indicators, traders can identify Bicara Therapeutics Common entry and exit signals to maximize returns
Bicara Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bicara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Bicara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bicara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0627 | |||
| Jensen Alpha | 0.3784 | |||
| Total Risk Alpha | (0.58) | |||
| Sortino Ratio | 0.0574 | |||
| Treynor Ratio | 1.97 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Bicara Stock Analysis
When running Bicara Therapeutics' price analysis, check to measure Bicara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicara Therapeutics is operating at the current time. Most of Bicara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicara Therapeutics' price. Additionally, you may evaluate how the addition of Bicara Therapeutics to your portfolios can decrease your overall portfolio volatility.